<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33891283</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-3524</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>39</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Neurotoxicity research</Title>
          <ISOAbbreviation>Neurotox Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Potential of Amantadine to Ameliorate Glutamate-Induced Pyramidal Cells Toxicity in Juvenile Rat' Brain Cortex.</ArticleTitle>
        <Pagination>
          <StartPage>1203</StartPage>
          <EndPage>1210</EndPage>
          <MedlinePgn>1203-1210</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12640-021-00365-7</ELocationID>
        <Abstract>
          <AbstractText>Glutamate (Gt) neurotoxicity contributes to a wide spectrum of neurological conditions. Loss of glutamate transporters leads to intracellular Gt accumulation. Amantadin (AMn) is a non-competitive N-methyl-D-aspartate (NMDA) antagonist that can partially inhibit Gt transporters and influence protein phosphatase 2A subunit B (PP-2A-B) activity. Herein, we investigate the potential of AMn administered in the early life stages to reverse the Gt-induced changes in the cerebral cortex in the rat model. We report that AMn can reverse Gt-induced structural changes in the brain cortex and increase PP-2A activity. Additionally, PP-2A-B activity in the AMn + Gt-treated group was comparable to controls. Moreover, administration of AMn leads to a decrease of apoptotic index in the Gt-treated individuals. We suggest that severe histopathological changes observed in Gt group could be attributed to the decreased PP-2A expression causing an imbalance between phosphatase and protein kinase activities and leading to a strong positive TUNEL reaction. We provide a short summary of the current state of knowledge regarding the role of PP-2A-B in the Gt-induced neurotoxicity and AMn treatment and discuss the potential of amantadine as a potential therapeutic agent.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ahmed</LastName>
            <ForeName>Ahmed S</ForeName>
            <Initials>AS</Initials>
            <Identifier Source="ORCID">0000-0002-8230-2795</Identifier>
            <AffiliationInfo>
              <Affiliation>Anatomy and Embryology Department, College of Medicine, Tanta University, Tanta, 31511, Egypt. ahmedsahmed.tanta@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hantash</LastName>
            <ForeName>Ehab M</ForeName>
            <Initials>EM</Initials>
            <AffiliationInfo>
              <Affiliation>Anatomy and Embryology Department, College of Medicine, Tanta University, Tanta, 31511, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zakaria</LastName>
            <ForeName>Soha S</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Imam Muhammad Bin Saud Islamic University, Riyadh, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Medical Biochemistry and Molecular Biology Department, College of Medicine, Tanta University, Tanta, 31511, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>04</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Neurotox Res</MedlineTA>
        <NlmUniqueID>100929017</NlmUniqueID>
        <ISSNLinking>1029-8428</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>3KX376GY7L</RegistryNumber>
          <NameOfSubstance UI="D018698">Glutamic Acid</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>BF4C9Z1J53</RegistryNumber>
          <NameOfSubstance UI="D000547">Amantadine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.1.3.16</RegistryNumber>
          <NameOfSubstance UI="D054648">Protein Phosphatase 2</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000547" MajorTopicYN="N">Amantadine</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015259" MajorTopicYN="N">Dopamine Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018698" MajorTopicYN="N">Glutamic Acid</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054648" MajorTopicYN="N">Protein Phosphatase 2</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017966" MajorTopicYN="N">Pyramidal Cells</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Amantadine</Keyword>
        <Keyword MajorTopicYN="N">Cerebral cortex</Keyword>
        <Keyword MajorTopicYN="N">Glutamate</Keyword>
        <Keyword MajorTopicYN="N">PP-2A</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>23</Day>
          <Hour>12</Hour>
          <Minute>34</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33891283</ArticleId>
        <ArticleId IdType="doi">10.1007/s12640-021-00365-7</ArticleId>
        <ArticleId IdType="pii">10.1007/s12640-021-00365-7</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>References</Title>
        <Reference>
          <Citation>Ahmed S (2020) Tocotrienol-rich fraction of palm oil attenuates type II collagen-induced temporomandibular joint rheumatoid arthritis in rats for future clinical application. Eur Sci J 16(24):124–135</Citation>
        </Reference>
        <Reference>
          <Citation>Anwar Khan F, Chen X, Shoaib M, Shah M, Ahmad F, Khan H, Ur Rehman F, Saeed M, Ahmad I, Ahmad I, Guo A (2019) Two dimensional gel electrophoresis (2-DE) for high-throughput proteome analyses of Mycoplasma bovis. Acta Biochim Pol 22;66(3):321–327</Citation>
        </Reference>
        <Reference>
          <Citation>Baj A, Moro E, Bistoletti M, Orlandi V, Crema F, Giaroni C (2019) Glutamatergic signaling along the microbiota-gut-brain axis. Int J Mol Sci 25;20(6):1482</Citation>
        </Reference>
        <Reference>
          <Citation>Barker-Haliski M, White HS (2015) Glutamatergic mechanisms associated with seizures and epilepsy. Cold Spring Harb Perspect Med 22;5(8):a022863</Citation>
        </Reference>
        <Reference>
          <Citation>Bido S, Marti M, Morari M (2011) Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels. J Neurochem 118(6):1043–1055</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-4159.2011.07376.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyko M, Gruenbaum SE, Gruenbaum BF, Shapira Y, Zlotnik A (2014) Brain to blood glutamate scavenging as a novel therapeutic modality: a review. J Neural Transm (Vienna) 121(8):971–979</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00702-014-1181-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Pittà M, Brunel N (2016) Modulation of synaptic plasticity by glutamatergic gliotransmission: a modeling study. Neural Plast 2016:7607924</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2016/7607924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duman RS, Sanacora G, Krystal JH (2019) Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 3;102(1):75–90</Citation>
        </Reference>
        <Reference>
          <Citation>Ervolino E, Statkievicz C, Toro LF, de Mello-Neto JM, Cavazana TP, Issa JPM, Dornelles RCM, de Almeida JM, Nagata MJH, Okamoto R, Casatti CA, Garcia VG, Theodoro LH (2019) Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate. Bone 120:101–113</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bone.2018.10.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gong CX, Lidsky T. Wegiel J¸ Zuck L, Grundke-Iqbal I, Iqbal K (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 275(8):5535–44</Citation>
        </Reference>
        <Reference>
          <Citation>Haroon E, Chen X, Li Z, Patel T, Woolwine BJ, Hu XP, Felger JC, Miller AH (2018) Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia. Transl Psychiatry 10;8(1):189</Citation>
        </Reference>
        <Reference>
          <Citation>Houge G, Haesen D, Vissers LE, Mehta S, Parker MJ, Wright M, Vogt J, McKee S, Tolmie JL, Cordeiro N, Kleefstra T, Willemsen MH, Reijnders MR, Berland S, Hayman E, Lahat E, Brilstra EH, van Gassen KL, Zonneveld-Huijssoon E, de Bie CI, Hoischen A, Eichler EE, Holdhus R, Steen VM, Døskeland SO, Hurles ME, FitzPatrick DR, Janssens V (2015) B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability. J Clin Invest 3;125(8):3051–62</Citation>
        </Reference>
        <Reference>
          <Citation>Kang TH, Bae KH, Yu MJ, Kim WK, Hwang HR, Jung H, Lee PY, Kang S, Yoon TS, Park SG, Ryu SE, Lee SC (2007) Phosphoproteomic analysis of neuronal cell death by glutamate-induced oxidative stress. Proteomics 7(15):2624–2635</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pmic.200601028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koh PO (2007) 17Beta-estradiol prevents the glutamate-induced decrease of Akt and its downstream targets in HT22 cells. J Vet Med Sci 69(3):285–288</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1292/jvms.69.285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koh PO (2011) Focal cerebral ischemia reduces protein phosphatase 2A subunit B expression in brain tissue and HT22 cells. Lab Anim Res 27(1):73–76</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5625/lar.2011.27.1.73</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lei P, Ayton S, Finkelstein DI, Adlard PA, Masters CL, Bush AI (2010) Tau protein: relevance to Parkinson’s disease. Int J Biochem Cell Biol 42(11):1775–1778</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2010.07.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leslie SN, Nairn AC (2019) cAMP regulation of protein phosphatases PP1 and PP2A in brain. Biochim Biophys Acta Mol Cell Res 1866(1):64–73</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2018.09.006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu R, Wang JZ (2009) Protein phosphatase 2A in Alzheimer’s disease. Pathophysiology 16(4):273–277</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pathophys.2009.02.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marvin JS, Scholl B, Wilson DE, Podgorski K, Kazemipour A, Müller JA, Schoch S, Quiroz FJU, Rebola N, Bao H, Little JP, Tkachuk AN, Cai E, Hantman AW, Wang SS, DePiero VJ, Borghuis BG, Chapman ER, Dietrich D, DiGregorio DA, Fitzpatrick D, Looger LL (2018) Stability, affinity, and chromatic variants of the glutamate sensor iGluSnFR. Nat Methods 15(11):936–939</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41592-018-0171-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakano T, Hasegawa T, Suzuki D, Motomura E, Okada M (2019) Amantadine combines astroglial system Xc-activation with glutamate/NMDA receptor inhibition. Biomolecules 17;9(5):191</Citation>
        </Reference>
        <Reference>
          <Citation>Park DJ, Kang JB, Shah MA, Koh PO (2019) Quercetin alleviates the injury-induced decrease of protein phosphatase 2A subunit B in cerebral ischemic animal model and glutamate-exposed HT22 cells. J Vet Med Sci 81(7):1047–1054</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1292/jvms.19-0094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park HJ, Lee KW, Oh S, Yan R, Zhang J, Beach TG, Adler CH, Voronkov M, Braithwaite SP, Stock JB, Mouradian MM (2018) Protein phosphatase 2A and its methylation modulating enzymes LCMT-1 and PME-1 are dysregulated in tauopathies of progressive supranuclear palsy and Alzheimer disease. J Neuropathol Exp Neurol 1;77(2):139–148</Citation>
        </Reference>
        <Reference>
          <Citation>Park HJ, Lee KW, Park ES, Oh S, Yan R, Zhang J, Beach TG, Adler CH, Voronkov M, Braithwaite SP, Stock JB, Mouradian MM (2016) Dysregulation of protein phosphatase 2A in Parkinson disease and dementia with lewy bodies. Ann Clin Transl Neurol 3(10):769–780</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acn3.337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinky NF, Wilkie CM, Barnes JR, Parsons MP (2018) Region- and activity-dependent regulation of extracellular glutamate. J Neurosci 6;38(23):5351–5366</Citation>
        </Reference>
        <Reference>
          <Citation>Shredah M, Nagy D (2017) Effect of monosodium glutamate on the sublingual salivary glands of rats (histological and histochemical study). Egypt Dent J 63(4)(Oral Medicine, X-Ray, Oral Biology &amp; Oral Pathology):3263–3270</Citation>
        </Reference>
        <Reference>
          <Citation>Sontag JM, Sontag E (2014) Protein phosphatase 2A dysfunction in Alzheimer's disease. Front Mol Neurosci 11;7:16</Citation>
        </Reference>
        <Reference>
          <Citation>Tian H, Li L, Liu XX, Zhang Y (2006) Antitumor effect of antisense ornithine decarboxylase adenovirus on human lung cancer cells. Acta Biochim Biophys Sin (Shanghai) 38(6):410–416</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1745-7270.2006.00176.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Xie R, Kou X, Liu Y, Qi C, Liu R, You W, Gao J, Gao X (2019) A protein phosphatase 2A deficit in the hippocampal CA1 area impairs memory extinction. Mol Brain 21;12(1):51</Citation>
        </Reference>
        <Reference>
          <Citation>Yin J, Li R, Liu W, Chen Y, Zhang X, Li X, He X, Duan C (2018) Neuroprotective effect of protein phosphatase 2A/tristetraprolin following subarachnoid hemorrhage in rats. Front Neurosci 27;12:96</Citation>
        </Reference>
        <Reference>
          <Citation>Zhou Y, Danbolt NC (2014) Glutamate as a neurotransmitter in the healthy brain. J Neural Transm (Vienna) 121(8):799–817</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00702-014-1180-8</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
